The FDA has approved INNOPHARMA’s Abbreviated New Drug Application (ANDA) for olanzapine injection (the generic equivalent of ZyprexaR injection).

As the developer of this generic injectable drug, INNOPHARMA entered into an agreement with Sandoz, pursuant to which Sandoz will sell, market and distribute the product in the United States.